|
AZIN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.24020049574858E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54169998989317E-09 |
| Normal-vs-Stage2 |
1.478430E-03 |
| Normal-vs-Stage3 |
1.33849999972568E-08 |
| Normal-vs-Stage4 |
2.90250000001269E-06 |
| Stage1-vs-Stage2 |
4.419000E-01 |
| Stage1-vs-Stage3 |
1.174610E-01 |
| Stage1-vs-Stage4 |
6.570000E-01 |
| Stage2-vs-Stage3 |
9.160400E-02 |
| Stage2-vs-Stage4 |
3.409200E-01 |
| Stage3-vs-Stage4 |
4.445400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17380000058876E-09 |
| Normal-vs-AfricanAmerican |
1.34690003594784E-09 |
| Normal-vs-Asian |
2.941400E-01 |
| Caucasian-vs-AfricanAmerican |
1.936490E-02 |
| Caucasian-vs-Asian |
3.320600E-01 |
| AfricanAmerican-vs-Asian |
4.875700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.13900050186567E-10 |
| Normal-vs-Female |
1.48739999983327E-07 |
| Male-vs-Female |
3.952000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.370300E-04 |
| Normal-vs-Age(41-60Yrs) |
7.9762999982691E-08 |
| Normal-vs-Age(61-80Yrs) |
2.950599986562E-09 |
| Normal-vs-Age(81-100Yrs) |
3.978600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.428600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.083000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.356200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.296600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.999000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.246800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.740100E-02 |
| Normal-vs-Grade 2 |
2.00729999999538E-06 |
| Normal-vs-Grade 3 |
2.80764300697456E-12 |
| Normal-vs-Grade 4 |
1.47439999997889E-06 |
| Grade 1-vs-Grade 2 |
5.852200E-01 |
| Grade 1-vs-Grade 3 |
1.464430E-01 |
| Grade 1-vs-Grade 4 |
1.786760E-01 |
| Grade 2-vs-Grade 3 |
9.743900E-03 |
| Grade 2-vs-Grade 4 |
1.854590E-01 |
| Grade 3-vs-Grade 4 |
7.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.69429999714077E-08 |
| Normal-vs-ccB subtype |
1.60620999999361E-05 |
| ccA subtype-vs-ccB subtype |
7.352400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.21050000315648E-08 |
| Normal-vs-N1 |
2.134500E-02 |
| N0-vs-N1 |
7.771400E-01 |
|
|
